A Search Service for Abbreviation / Long Form

■ Search Result - Abbreviation : SCCHN

Search Conditions:
Search Keyword : SCCHN
Search Method : Exact match.
Research Area:

Results:  
Abbreviation: SCCHN
Appearance Frequency: 1437 time(s)
Long forms: 8

Display Settings:
[Entries Per Page]
 per page
Page Control
Page: of
Long Form No. Long Form Research Area Co-occurring Abbreviation PubMed/MEDLINE Info. (Year, Title)
squamous cell carcinoma of the head and neck
(1417 times)
Neoplasms
(1012 times)
EGFR (138 times)
CI (98 times)
OS (96 times)
1982 [Palliative chemotherapy of recurring squamous cell carcinomas of the ENT field with the combination cis-diamminodichloroplatinum (II)/adriamycin].
squamous cell head and neck cancer
(9 times)
Neoplasms
(8 times)
CRT (1 time)
DM (1 time)
EFS (1 time)
2002 Association between head and neck cancer and microsomal epoxide hydrolase genotypes.
SCC of the head and neck
(6 times)
Neoplasms
(4 times)
SCC (5 times)
PNI (2 times)
CI (1 time)
1998 Frequent mutation of p16 in squamous cell carcinoma of the head and neck.
several controversies in the management of head and neck cancer
(1 time)
Drug Therapy
(1 time)
CRT (1 time)
ICPi (1 time)
LA-SCCHN (1 time)
2021 Current status of systemic therapy in head and neck cancer.
signal transducers in head and neck cancer
(1 time)
Neoplasms
(1 time)
EGFR (1 time)
2005 Iressa (ZD 1839) inhibits phosphorylation of three different downstream signal transducers in head and neck cancer (SCCHN).
Some patients with unresectable or incompletely resected head-and-neck cancer
(1 time)
Neoplasms
(1 time)
--- 2021 Comparison of Conventional Fractionation and Accelerated Fractionation With Concomitant Boost for Radiotherapy of Non-metastatic Stage IV Head-and-Neck Cancer.
squamous cancer cell line of head and neck
(1 time)
Molecular Biology
(1 time)
AI-2 (1 time)
EGFR (1 time)
2013 Autonomous bacterial localization and gene expression based on nearby cell receptor density.
subpopulation of patients with recurrent, unresectable head and neck cancer
(1 time)
Drug Therapy
(1 time)
DCTD (1 time)
EGFR (1 time)
LFS (1 time)
2007 INGN 201: Ad-p53, Ad5CMV-p53, adenoviral p53, p53 gene therapy--introgen, RPR/INGN 201.